Dr. Dónal Palcic:

Probably, we would have two different companies. One of the biggest reasons Eir stated it withdrew - another was the uncertainty around the regulation - was that Eir's access price in the intervention area would have been lower than ComReg's regulated price that it must charge and, through regulatory equivalence, Eir would have to offer that price to everybody.